“…Interestingly, CYP3A-based drug interaction with beverages is confined to grapefruit juice (GFJ), which inhibits CYP3A metabolic activity and thus elevates the bioavailability of drugs that undergo intestinal metabolism mediated by CYP3A (Bailey et al, 1989(Bailey et al, , 1991He et al, 1998;Fukuda et al, 2000). On the other hand, OATP2B1mediated drug interaction with beverages has been shown by coadministration with GFJ, orange juice (OJ), apple juice (AJ), and, most recently, green tea, which inhibits OATP2B1 transport activity, resulting in a decrease of the bioavailability of substrate drugs (Dresser et al, 2002;Misaka et al, 2014;Yu et al, 2017;Abe et al, 2018).…”